PLURPluri Inc.

Nasdaq pluri-biotech.com


$ 5.86 $ 0.58 (9.64 %)    

Tuesday, 28-May-2024 14:30:00 EDT
QQQ $ 454.82 $ 1.73 (0.38 %)
DIA $ 398.57 $ -2.04 (-0.52 %)
SPY $ 530.36 $ 0.37 (0.07 %)
TLT $ 91.26 $ -1.31 (-1.43 %)
GLD $ 225.37 $ 2.27 (1.05 %)
$ 6.6
$ 5.57
$ 0.00 x 0
$ 6.61 x 100
$ 5.57 - $ 5.86
$ 3.45 - $ 8.56
5,415
na
35.57M
$ 1.41
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 02-12-2024 12-31-2023 10-Q
3 11-13-2023 09-30-2023 10-Q
4 09-12-2023 06-30-2023 10-K
5 05-09-2023 03-31-2023 10-Q
6 02-13-2023 12-31-2022 10-Q
7 11-10-2022 09-30-2022 10-Q
8 09-21-2022 06-30-2022 10-K
9 05-09-2022 03-31-2022 10-Q
10 02-07-2022 12-31-2021 10-Q
11 11-08-2021 09-30-2021 10-Q
12 09-13-2021 06-30-2021 10-K
13 05-06-2021 03-31-2021 10-Q
14 02-08-2021 12-31-2020 10-Q
15 11-05-2020 09-30-2020 10-Q
16 09-10-2020 06-30-2020 10-K
17 05-11-2020 03-31-2020 10-Q
18 02-06-2020 12-31-2019 10-Q
19 11-07-2019 09-30-2019 10-Q
20 09-12-2019 06-30-2019 10-K
21 05-06-2019 03-31-2019 10-Q
22 02-06-2019 12-31-2018 10-Q
23 11-07-2018 09-30-2018 10-Q
24 09-12-2018 06-30-2018 10-K
25 05-09-2018 03-31-2018 10-Q
26 02-06-2018 12-31-2017 10-Q
27 11-07-2017 09-30-2017 10-Q
28 09-07-2017 06-30-2017 10-K
29 05-08-2017 03-31-2017 10-Q
30 02-08-2017 12-31-2016 10-Q
31 11-07-2016 09-30-2016 10-Q
32 09-07-2016 06-30-2016 10-K
33 05-09-2016 03-31-2016 10-Q
34 02-08-2016 12-31-2015 10-Q
35 11-05-2015 09-30-2015 10-Q
36 09-09-2015 06-30-2015 10-K
37 05-06-2015 03-31-2015 10-Q
38 02-05-2015 12-31-2014 10-Q
39 11-06-2014 09-30-2014 10-Q
40 09-11-2014 06-30-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 pluri-introduces-groundbreaking-immune-cell-expansion-technology-secures-new-us-patent

Leading biotechnology company, Pluri Inc. (NASDAQ:PLUR) (TASE:PLUR) ("Pluri" or the "Company"), which transform...

 pluri-receives-patent-approval-for-3d-bioreactor-technology-in-plant-cell-cultivation

The patent titled "A System for 3D Cultivation of Plant Cells and Methods of Use" represents a major breakthrough in Pl...

 pluri-unveils-sustainable-cell-based-coffee-to-tackle-global-coffee-crisis

Pluri to leverage its proprietary 3D technology platform to develop cell-based products for the coffee industry under its new...

 stocks-that-hit-52-week-lows-on-monday

  During Monday, 102 stocks hit new 52-week lows.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION